Ransomware Group: DRAGONFORCE

VICTIM NAME: Lyomark Pharma

NOTE: No files or stolen information are [exfiltrated/downloaded/taken/hosted/seen/reposted/disclosed] by RedPacket Security. Any legal issues relating to the content of the files should be directed at the attackers directly, not RedPacket Security. This blog is simply posting an editorial news post informing that a company has fallen victim to a ransomware attack. RedPacket Security is in no way affiliated or aligned with any ransomware threat actors or groups and will not host infringing content. The information on this page is fully automated and redacted whilst being scraped directly from the DRAGONFORCE Onion Dark Web Tor Blog page.

AI Generated Summary of the Ransomware Leak Page

The ransomware leak page associated with Lyomark Pharma, a contract manufacturer and active ingredient manufacturer in the healthcare sector based in Germany, outlines several key points regarding the breach. The leak was reported on October 4, 2024, revealing significant concerns over the data security measures that may have been compromised. The company, established in 1989, has carved out a niche in the pharmaceutical industry, specializing in sterile lyophilized and liquid products. This incident possibly compromises sensitive data related to 16 users, with two URLs likely pointing to exposed information. No specific employee or third-party information was detailed in the leak.

The content of the page emphasized the importance of data protection in the pharmaceutical industry, particularly for companies like Lyomark Pharma that deal with critical products. The leak page represented by the group identified as “dragonforce” did not showcase any screenshots or additional visual content. However, it indicated the organization’s approach to data security would be scrutinized in light of this incident. The compromise date remains unspecified, raising questions about the timeframe of the breach and prompting conversations around cybersecurity practices, regulations, and responsibilities within the healthcare sector.